Spyre Therapeutics, Inc. (SYRE)
74.05
-0.27
(-0.36%)
USD |
NASDAQ |
May 22, 16:00
73.15
-0.90
(-1.22%)
After-Hours: 20:00
Spyre Therapeutics Total Liabilities (Quarterly) : 93.14M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 24.46M |
| Cogent Biosciences, Inc. | 295.31M |
| Revolution Medicines, Inc. | 753.82M |
| Apellis Pharmaceuticals, Inc. | 667.61M |
| Replimune Group, Inc. | 123.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 763.95M |
| Shareholders Equity (Quarterly) | 670.81M |
| Current Ratio | 8.971 |